Leading commercial air purification manufacturer, Fellowes, is pleased to announce its AeraMax Pro AM3 and AM4 air purifiers have been proven to be effective in eliminating aerosolised concentration of SARS-CoV-2, the highly transmissible and pathogenic virus responsible for the COVID-19 disease pandemic, by 99.9999% through a single air pass test of the purifier.
As part of its continued commitment to clean air, the manufacturer volunteered its AeraMax Pro AM3 and 4 air purifiers to be tested against the health-threatening airborne-transmitted COVID-19 virus contaminants at the University of Genoa, School of Medicine, Department of Experimental Medicine. The study found that the Fellowes air purifiers neutralised the airborne viral load of SARS-CoV-2 entirely and were able to remove 99.9999% of the aerosolised SARS-CoV-2 through a single pass of the purifier.
The result comes following the manufacturer’s recent studies released in early 2021, where its AeraMax Pro products showed a 99.99% airborne reduction of a coronavirus surrogate and 99.9% removal of the H1N1 flu virus (commonly known as Swine Flu).
On the latest test results, Darryl Brunt, Country Head - UK & Ireland at Fellowes Brands said: “It is now widely accepted by the scientific community that airborne transmission of aerosol droplets is the primary cause of the transmission of COVID-19. As such, worldwide bodies including the CDC and ASHRAE have continued to recommend infection control policies that include the use of portable air cleaners featuring HEPA filtration, to aid in the protection against SARS-Cov-2. We are thrilled that this latest study proves how effective our unique Aeramax Pro technology is in helping to reduce the transmission of harmful viruses that cause deadly diseases such as COVID-19.”
He continued: “We are committed to expanded testing with fully accredited and independent laboratories and for building owners, landlords and occupants, we see this result as further reassurance that Fellowes AeraMax Pro air purifiers are effective in cleaning indoor air.”
On the study, Dr. Alberto Izzotti at the University of Genoa, School of Medicine, Department of Experimental Medicine said: “The AeraMax Pro AM3 and 4 air purifiers were evaluated in extreme laboratory operating conditions, certainly much more critical and difficult than the real environmental situation. This situation was purposely designed since it is necessary to test the effectiveness of similar sanitising devices in critical conditions to guarantee their effective performance. Despite the extreme conditions used, the Fellowes air purification technology was able to neutralise the airborne viral load."
For over a decade, Fellowes AeraMax air purifiers have been a leading choice for localised air purification. Fellowes is the only solution that combines True HEPA filtration with EnviroSmart™ and PureView™ Technologies. EnviroSmart utilises multiple sensors to continuously monitor contaminants, room occupancy and automatically adjust to provide maximum protection. PureView makes the invisible, visible with real-time screen updates on air quality and machine performance. This immediate feedback instils peace of mind for room occupants.
To read more about Fellowes independent testing, or for more information about Fellowes AeraMax Pro air purifiers, visit www.aeramaxpro.com/uk